Health
Australian firm says its nasal spray reduced coronavirus growth in animal study – PharmaLive
Ena Respiratory said a nasal spray that the Australian biotech company is developing to improve the human immune system to fight common cold and flu significant…
Australian firm says its nasal spray reduced coronavirus growth in animal study
SYDNEY (Reuters) – Australian biotech company Ena Respiratory said on Monday that a nasal spray it is developing to improve the human immune system to fight common cold and flu significantly reduced the growth of the coronavirus in a recent study on animals.
A study on ferrets showed the product dubbed INNA-051, which could be used complementary to vaccines, lowered the levels of the virus that causes COVID-19 by u…
-
General11 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Noosa News20 hours agoJane Edmanson hangs up her Gardening Australia hat, reflects on labour of love behind show’s success
-
General23 hours ago‘Brumby Bill’ recognising heritage value of wild horses to be scrapped in NSW
-
Business23 hours ago3 ASX stocks I’d trust with $10,000 for the next decade